Data sources
SQRTPA
The Scandinavian Quality Registry for Thyroid, Parathyroid and Adrenal Surgery (SQRTPA, www.sqrtpa.se) started in 2004 and is recognized by the Swedish National Board for Health and Social Welfare as the national quality registry for endocrine surgical procedures in Sweden. Data are entered online prospectively by the surgeon or a specialized nurse. Currently, 36 Swedish units report to the registry, covering almost 100% of all thyroid procedures in Sweden [2, 9]. Coverage is assessed by calculating the proportion of patients registered in SQRTPA in relation to those registered in the Swedish National Patient register. Data quality for the registered patients is evaluated by external audit and by comparing registered data to hospital medical records. The audit has demonstrated good data quality, with an error rate of <5% [9].
Swedish National Registry for Prescribed Drugs
The Swedish Prescribed Drug Register (SPDR) was launched in 2005 and contains information about age, sex and unique identification of the patient, Anatomical Therapeutic Chemical (ATC) Classification Code, drug dose, package size, date for prescription, day when the drug was bought at the pharmacy, as well as the prescriber’s profession and practice. The data are entered in an automatical fashion by direct transfer from the computer record. The prescribed drugs included in the register, accounted for 84% of the total utilization [10].
The Swedish National Patient register
As of 1987, the Swedish National patient register (NPR) includes all in-hospital patient care in Sweden. The number of surgical procedures and diagnoses at all hospitals in Sweden can be retrieved from this register. Data are entered by direct transfer from computer record system in each county. Underreporting for inpatient data has been estimated to less than one percent [11].
Study cohort
Patients below the age of 18 operated with total thyroidectomy January 1, 2004 to December 31, 2014 were identified in the SQRTPA.
The primary endpoint was the incidence of permanent postoperative hypoparathyroidism defined as medication with active vitamin D for more than 6 months after thyroidectomy in the SPDR.
Exclusion criteria were previous thyroid and parathyroid surgery and ongoing treatment with vitamin D at the time of surgery. Permanent hypoparathyroidism was defined as prescription and expedition of active vitamin D (dihydrotachysterol, ATC A11CC02, alfacalcidol, ATC A11CC03 or calcitriol, ATC A11CC04) in the first 180 days after surgery and any time after 180 days after surgery. Data on age, sex, indication for thyroidectomy, and lymph node dissection, number of identified parathyroid glands, parathyroid auto transplantation, operation time, thyroid specimen weight, and serum calcium at discharge and at 6 weeks postoperatively were retrieved. Surgical volume and the number of in-patient events including the diagnosis were extracted from the NPR.
Hospital volume of thyroid surgery was defined as low when less than 50 operations were done per year, median when 50–100, and high when more than 100 thyroid operations were performed annually.
Statistical analysis
Descriptive statistics were performed, and results calculated as medians with interquartile ranges (IQR) and numbers with column percentages. Differences between groups were evaluated with Mann–Whitney and Chi-square or Fishers exact test, where appropriate.
The risk of permanent hypoparathyroidism was investigated with uni- and multivariable logistic regression, yielding odds ratios (OR) with 95 percent confidence intervals (CI). The multivariable model included factors deemed to potentially affect risk of hypoparathyroidism: age at surgery (continuous), sex, hospital volume in categories, type of thyroid disease, number of identified parathyroid glands, parathyroid auto transplantation (yes or no), operation time (in categories), thyroid specimen weight (in categories) and whether lymph node dissection was performed or not. All statistical analyses were made using STATA version 12 (StataCorp LP, College station, USA).
Ethical considerations
The ethical committee at Lund University approved the study (2011/740, 2015/543 and 2016/83).